Indogulf Cropsciences IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

Indogulf Cropsciences is engaged in the business of manufacturing of crop protection products, plant nutrients and biologicals in India. They manufacture Spiromesifen technical with the minimum purity of 96.5% in 2019. They are also one of the first few indigenous manufacturers of Pyrazosulfuron Ethyl technical, with the minimum purity of 97% indigenously in India and commenced production in 2018. They are also a growing exporter of crop protection, plant nutrients and biologicals products and they exported their products to over 34 countries.

Indogulf Cropsciences, an Book Built Issue amounting to ₹ 200.00 Crores, consisting an Fresh Issue of 144.14 Lakh Shares worth ₹ 160.00 Crores and an Offer for Sale of 36.03 Lakh Shares totaling to ₹ 40.00 CroresThe subscription period for the Indogulf Cropsciences IPO opens on June 26, 2025, and closes on June 30, 2025. The allotment is expected to be finalized on or about Tuesday, July 01, 2025, and the shares will be listed on the BSE & NSE with a tentative listing date set on or about Thursday, July 03, 2025.

The Share Price Band of Indogulf Cropsciences IPO is set at ₹ 105 to ₹ 111 per equity share. The Market Capitalisation of the Indogulf Cropsciences Limited at IPO price of ₹ 111 per equity share will be ₹ 701.54 Crores. The lot size of the IPO is 135 shares. Retail investors are required to invest a minimum of ₹ 14.985, while the minimum investment for High-Net-Worth Individuals (HNIs) is 14 lots (1,890 shares), amounting to ₹ 2,09,790.

Systematix Corporate Services Limited is the book running lead manager of the Indogulf Cropsciences IPO, while Bigshare Services Private Limited is the registrar for the issue. 

Indogulf Cropsciences Limited IPO GMP Today
The Grey Market Premium of Indogulf Cropsciences Limited IPO is expected to be ₹ 11 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.

Indogulf Cropsciences Limited IPO Live Subscription Status Today: Real-Time Update
Indogulf Cropsciences will be open for its subscription on 26 June, 2025.

Indogulf Cropsciences Limited Day Wise IPO GMP Trend

Date

IPO Price

Expected Listing Price

GMP

Last Updated 

24 June 2025 ₹ 111 ₹ 122 ₹ 11 (9.90%) 05:00 PM; 24 June 2025


Indogulf Cropsciences Limited IPO Allotment Date - Step by Step Guide to Check Allotment Status Online
Indogulf Cropsciences IPO allotment date is 01 July, 2025, Tuesday. Indogulf Cropsciences IPO Allotment will be out on 1st July, 2025 and will be live on Registrar Website from the allotment date. 
Check Indogulf Cropsciences IPO Allotment Status here. Here's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Indogulf Cropsciences Limited IPO from the dropdown list of IPOs
- Enter your application number, PAN, or DP Client ID
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.

Objectives of Indogulf Cropsciences Limited IPO
Indogulf Cropsciences proposes to utilise the Net Proceeds towards the following objects: 
1. ₹ 650.00 Million is required for funding working capital requirements of the Company;
2. ₹ 341.17 Million is required for repayment/prepayment, in full or in part, of certain outstanding borrowings availed by the Company;
3. ₹ 140.00 Million is required for capital expenditure of the Company for setting up an in-house dry flowable (DF) plant at Barwasni, Sonipat, Haryana; and
4. General corporate purposes (collectively, the “Objects”).

Refer to Indogulf Cropsciences Limited RHP for more details about the Company.

Indogulf Cropsciences IPO Details

IPO Date June 26, 2025 to June 30, 2025
Listing Date July 03, 2025
Face Value ₹ 10.00
Price ₹ 105 to ₹ 111 per share
Lot Size 135 Equity Shares
Total Issue Size 1,80,18,017 Equity Shares (aggregating up to ₹ 200.00 Cr)
Fresh Issue 1,44,14,414 Equity Shares (aggregating to ₹ 160.00 Cr)
Offer for Sale 36,03,603 Equity Shares (aggregating to ₹ 40.00 Cr)
Issue Type Book Built Issue
Listing At BSE & NSE
Share holding pre issue 4,87,87,456
Share holding post issue 6,32,01,870

Indogulf Cropsciences IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 135 ₹14,985
Retail (Max) 13 1,755 ₹1,94,805
S-HNI (Min) 14 1,890 ₹2,09,790
S-HNI (Max) 66 8,910 ₹9,89,010
B-HNI (Min) 67 9,045 ₹10,03,995

Indogulf Cropsciences IPO Timeline (Tentative Schedule)

IPO Open Date Thursday, June 26, 2025
IPO Close Date Monday, June 30, 2025
Basis of Allotment Tuesday, July 01, 2025
Initiation of Refunds Wednesday, July 02, 2025
Credit of Shares to Demat Wednesday, July 02, 2025
Listing Date Thursday, July 03, 2025
Cut-off time for UPI mandate confirmation 5 PM on June 30, 2025

Indogulf Cropsciences IPO Reservation

Investor Category Shares Offered Reservation %
QIB Portion 90,09,009 Not More than 50% of the Issue
Non-Institutional Investor Portion 27,02,703 Not Less than 15% of the Issue
Retail Shares Offered 63,06,306 Not Less than 35% of the Issue

Indogulf Cropsciences IPO Promoter Holding

Share Holding Pre Issue 96.87 %
Share Holding Post Issue 69.07 %

Indogulf Cropsciences IPO Subscription Status

Investor Category Shares Offered Shares Bid For No oF Times Subscribed
Qualified Institutional Buyers (QIB) - - 0
Non Institutional Investors(NIIS) - - 0
Retail Individual Investors (RIIs) - - 0
Total - - 0

About Indogulf Cropsciences Limited

BUSINESS OVERVIEW

Indogulf Cropsciences is engaged in the manufacturing of crop protection products, plant nutrients, and biologicals in India. The company is among the first few indigenous manufacturers of Pyrazosulfuron Ethyl technical with a minimum purity of 97% (Source: CareEdge Report) since 2018, and commenced production of Spiromesifen technical with 96.5% purity in 2019. Recognized as a ‘Two Star Export House’ by the Government of India, the company has exported to over 34 countries (Source: CareEdge Report).

Operations began in 1993, structured across three core verticals: crop protection, plant nutrients, and biologicals, catering to both retail and institutional customers. The product portfolio includes a wide range of formulations such as WDG, SC, CS, ULV, EW, SG, and FS, available in powder, granule, and liquid forms. These products address a wide spectrum of crops including cereals, pulses, oilseeds, fibre crops, plantations, fruits, and vegetables, focusing on crop yield improvement and sustainable agriculture.

The company also offers customizable contract manufacturing services aligned with client-specific formulation needs. Over the years, it has established strong business relationships with key clients including Krishi Rasayan Exports, Parijat Industries, BR Agrotech, Crystal Crop Protection, and Asasiat of Development for Agric & Trade Co., UAE. Major raw material suppliers include Coromandel International, GSP Crop Science, Dagro Chemical (China), Hubei Benxing (China), and MaxxGro Agrology.

Manufacturing operations span four facilities located in Samba (J&K), Nathupur-I & II, and Barwasni (Haryana), covering approximately 20 acres. The company has two subsidiaries: Indogulf Cropsciences Australia Pty Ltd (Sydney), facilitating OECD product registrations, and Abhiprakash Globus Pvt Ltd (Delhi), supporting market expansion and business development.

The company has a robust presence across 22 Indian states, 3 Union Territories, and over 34 countries. As of April 30, 2025, distribution is supported by 192 institutional business partners (B2B), 6,916 domestic distributors (B2C), 17 stock depots, 6 sales/branch offices, and 143 overseas partners, enabling extensive sales, promotion, and customer service reach.

As of April 30, 2025, the company had a marketing team of 293 employees. The Bankers to the Company are HSBC Limited and HDFC Bank Limited.

INDUSTRY ANALYSIS

Agrochemicals Industry Overview

Agrochemicals, primarily used for crop protection, play a crucial role in enhancing agricultural productivity by defending crops against pests, diseases, and weeds. According to the Food and Agriculture Organization (FAO), nearly 40% of food crops are lost annually due to such threats. Farmers rely on agrochemicals as the final input in the crop cycle to safeguard yields and ensure food security.

These chemicals are applied to seeds, soil, irrigation water, and crops in diluted doses, providing a reliable and effective solution to manage over 30,000 weed species, 3,000 nematode species, and 10,000 insect species. Agrochemicals are broadly classified into insecticides, herbicides, fungicides, and rodenticides, depending on the targeted pests. India ranks among the top five global producers of agrochemicals.


India – Crop Protection & Nutrition Demand Trends

India’s agrochemical market is witnessing robust growth, driven by increasing food demand, rising population, and government support through schemes like ‘Make in India’ and ‘Aatmanirbhar Bharat Abhiyan’. Despite challenges such as erratic monsoons, global slowdowns, and high input costs, consumption of nutrients and crop protection products increased in 2024.

Rising temperatures, unpredictable rainfall, and shrinking arable land are intensifying demand for agrochemical inputs. Favorable cost structures, skilled labor availability, and tax incentives further strengthen India's position as a global agrochemical supplier. Exports continue to rise, supported by India's competitive edge in low production costs.


India’s Global Position in Agrochemicals

  • 2nd largest agrochemical exporter (2022) and 3rd largest (2023) – WTO

  • Gained advantage post-COVID as global firms shift production from China to India

  • Backed by PLI schemes aimed at increasing domestic production and reducing import dependency

  • Expected rise in foreign investment due to favorable policy and cost structure


Agri-input Production in India

India's agri-input production surged at a CAGR of 16.4%, from 689 thousand tonnes in 2019 to 1,354 thousand tonnes in 2024. Pesticides hold the largest share (57%) and are projected to grow at a CAGR of 3.6% (2024–2029). Overall agri-input production is expected to grow at a CAGR of 6.9% during the same period.


Domestic Pesticide Industry Performance

The Indian pesticide market grew at a CAGR of 10.9%, reaching USD 1.37 billion in 2024, and is projected to grow at 8.8% CAGR (2024–2029). The industry primarily includes:

  • Insecticides – 35% market share

  • Fungicides – 29%

  • Herbicides – 18%


Pesticide Production and Export Trends

  • Pesticide output (42 technical grades) increased from 217 thousand tonnes (2018–19) to 280 thousand tonnes (2023–24) at 4.5% CAGR

  • Export volumes grew faster, from 461 to 630 thousand tonnes at 8.1% CAGR, while export value rose at 18.2% CAGR, from Rs. 23.7 billion to Rs. 34.7 billion

  • Export performance remained resilient, growing even during the pandemic, with a 22% volume growth in FY 2021–22


Pesticide Imports and Supply Chain Dependency

Although India remains a net exporter, imports rose at 8.4% CAGR, reaching 147 thousand tonnes in 2023–24, with China contributing over 60% of total imports. The value of imports grew at 6.4% CAGR, touching Rs. 116.7 billion.

Supply chain disruptions in China highlight India’s dependency on imported technical-grade insecticides. To mitigate risks, the PLI scheme is being expanded to promote domestic manufacturing of technicals, reduce reliance on imports, and strengthen backward integration.


Strategic Outlook

India is poised to emerge as a global manufacturing hub under the “China Plus One” strategy being adopted worldwide. Competitive labor costs, government incentives, and growing export opportunities position India to capitalize on rising global demand. The domestic industry’s continued focus on self-reliance, R&D, and supply chain resilience is expected to drive sustained growth in the coming years.

BUSINESS STRENGTHS

1. Diversified Product Portfolio Across Three Verticals
With over three decades of experience, Indogulf Cropsciences has evolved into a multi-product manufacturer in crop protection, plant nutrients, and biologicals. The product portfolio expanded from 198 products in FY2022 to 262 as of December 31, 2024, supported by in-house innovative processes. The range includes WDG, SC, CS, ULV, EW, SG, FS in various forms—powder, granule, and liquid. Innovative packaging, protected by three patents, incorporates QR codes for product details, enhancing safety, quality, and sustainability.

2. Established Domestic and International Distribution Network
The company maintains a pan-India presence across 22 states and 3 Union Territories, and exports to over 34 countries. As of April 30, 2025, the distribution network includes 192 institutional partners (B2B), 6,916 domestic distributors (B2C), 17 stock depots, 6 branch offices, and 143 overseas business partners, ensuring widespread customer reach and product promotion.

3. Backward Integrated Manufacturing Infrastructure
Adopting a backward integration strategy provides enhanced supply chain control, cost efficiency, and innovation potential. This approach supports alignment with long-term strategic goals while requiring careful planning and investment.

4. Robust R&D and Product Development Capabilities
The company operates an accredited R&D lab at Nathupur, Haryana, certified under ISO/IEC 17025:2017 by NABL. R&D efforts focus on developing new products and processes, upgrading 39 products, and improving production quality and cost-efficiency. These capabilities enable product diversification, respond to market evolution, and strengthen competitive positioning.

5. Experienced Leadership and Management Team
Promoted by Om Prakash Aggarwal (Chairman) and Sanjay Aggarwal (Managing Director), both with over 30 years of industry experience, the company benefits from strong strategic direction and deep sectoral expertise.

BUSINESS STRATEGIES

1. Expansion of Production Capacity for Cost Efficiency
Operations span four manufacturing facilities in Samba (Jammu & Kashmir) and three locations in HaryanaNathupur I, Nathupur II, and Barwasni—covering approximately 20 acres. Plans are in place to expand existing production capacities to enhance cost efficiency and scalability.

2. Growth of Product Portfolio Across All Verticals
Focus remains on launching new products and categories across crop protection, plant nutrients, and biologicals to meet evolving consumer preferences and capture greater market share. Expansion will target diversified price points and adjacent product segments.

3. Strengthening R&D Capabilities
Consistent investments in R&D infrastructure and technology aim to support cost-effective and scalable processes. R&D expenditure over recent fiscals has been strategically allocated under quality testing expenses, representing up to 0.30% of gross revenue. As of April 30, 2025, the product portfolio has grown to 288 products, all developed and validated through in-house R&D.

4. Expansion of Sales & Distribution and Foreign Registrations
The sales and distribution footprint includes 22 states, 3 Union Territories, and exports to over 34 countries. The distribution network consists of 192 institutional partners (B2B), 6,916 domestic distributors (B2C), 17 stock depots, 6 branch offices, and 143 international business partners. Efforts continue to expand market presence and secure international product registrations.

5. Cost Optimization Initiatives
Strategic focus on cost reduction and process optimization through SAP implementation, automated packaging, and job work utilization. The R&D team actively develops alternative formulations to reduce material costs. Ongoing monthly operational reviews, supported by analysis of financial data and performance metrics, help identify inefficiencies and enable economies of scale across manufacturing processes


BUSINESS RISK FACTORS & CONCERNS

1. Capital-Intensive Industry and Financing Risks
The agrochemicals sector demands substantial capital for infrastructure maintenance, equipment procurement, and technology upgrades. Any failure to secure additional financing in the future may negatively impact business operations, financial health, and growth plans.

2. Threat from Alternative Crop Protection Methods
Emerging alternatives like biotechnology products, pest-resistant seeds, and genetically modified (GM) crops may reduce the demand for traditional agrochemical products. Successful commercialization of pest-resistant seed traits could displace chemical-based solutions. In contrast, resistance among pests and weeds to agrochemicals could also decrease product effectiveness. Inability to adapt the product portfolio in response may lead to reduced sales and profitability.

3. Geographic Concentration of Manufacturing Facilities
Manufacturing units are concentrated in Samba (J&K) and Haryana (Nathupur I & II and Barwasni). Any regional disruption—whether political, environmental, or regulatory—could significantly impact production, delay deliveries, and damage industry reputation. Lack of operational diversification across other regions poses a strategic vulnerability.

Indogulf Cropsciences operates in a high-capital, highly competitive environment. The business faces risks related to funding constraints, evolving agricultural technologies, and geographic concentration of facilities. These factors may impact operational stability, product demand, and long-term growth if not proactively managed.

Indogulf Cropsciences Limited Financial Information (Restated Consolidated)

Amount in (₹ in Million)

Period Ended Dec 31, 2024 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Reserve of Surplus 2,166.41 2,080.07 1,796.04 1,568.69
Total Assets 5,978.14 5,422.49 5,175.10 4,135.91
Total Borrowings 2,063.04 1,545.62 1,892.18 1,013.78
Fixed Assets 373.69 390.05 626.27 504.58
Cash 71.54 29.16 36.87 47.93
Net Borrowing 1,991.50 1,516.46 1,855.31 965.85
Revenue 4,663.06 5,557.87 5,521.89 4,902.30
EBITDA 468.95 592.97 515.73 502.63
PAT 217.77 284.03 227.35 262.68
EPS 5.1 11.94 9.48 11.15

Note 1:- RoE, ROCE & RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2024 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price Post Issue, given in 
FINANCIAL EXPRESS.

Key Performance Indicator

KPI Values
EPS Pre IPO (Rs.) ₹ 11.94
EPS Post IPO (Rs.) ₹ 4.49
P/E Pre IPO 9.30
P/E Post IPO 24.70
ROE 12.19 %
ROCE 18.82 %
P/BV 1.65
Debt/Equity 0.67
RoNW 12.19 %

Indogulf Cropsciences Limited IPO Peer Comparison

Company Name EPS ROCE ROE P/E (x) P/Bv Debt/Equity RoNW (%)
Indogulf Cropscienes Limited ₹ 4.49 18.82 % 12.19 % 24.70 1.65 0.67 12.19 %
Aries Agro Limited ₹ 26.2 18.5 % 12.2 % 21.1 1.41 0.17 12.2 %
Basant Agro Tech India Limited ₹ 0.46 6.55 % 2.37 % 33.9 0.79 0.72 2.37 %
Best Agrolife Limited ₹ 29.6 12.9 % 9.95 % 11.0 1.01 0.63 9.95 %
Bhagiradha Chemicals & Industries Limited ₹ 1.07 5.19 % 8.39 % 275 5.58 0.13 8.39 %
Heranba Industries Limited ₹ 0.77 4.41 % 0.27 % 536 1.42 0.41 0.27 %
India Pesticides Limited ₹ 7.33 13.1 % 9.75 % 29.5 2.75 0.06 9.75 %
Dharmaj Crop Guard Limited ₹ 10.3 12.0 % 9.24 % 29.0 2.56 0.29 9.24 %
Indogulf Cropsciences Limited Contact Details

INDOGULF CROPSCIENCES LIMITED 

501, Gopal Heights Plot No – D-9, Netaji Subhash Place, New Delhi – 110034, Delhi, India
Contact Person : Sakshi Jain
Telephone : +91 11 4004 0417
Email : cs@groupindogulf.com
Website : 
https://groupindogulf.com/default.aspx

Indogulf Cropsciences IPO Registrar and Lead Manager(s)

Registrar : Bigshare Services Private Limited
Contact Person : Vinayak Morbale
Telephone : +91 22 6263 8200
Email : ipo@bigshareonline.com
Website : 
https://www.bigshareonline.com/

Lead Manager : Systematix Corporate Services Limited
Contact Person : Jinal Sanghvi / Kuldeep Singh
Telephone : +91 22 6704 8000
Email : mb.ipo@systematixgroup.in
Website : 
https://www.systematixgroup.in/

Indogulf Cropsciences IPO Review

Indogulf Cropsciences is engaged in the business of manufacturing of crop protection products, plant nutrients and biologicals in India. They manufacture Spiromesifen technical with the minimum purity of 96.5% in 2019. They are also one of the first few indigenous manufacturers of Pyrazosulfuron Ethyl technical, with the minimum purity of 97% indigenously in India and commenced production in 2018. They are also a growing exporter of crop protection, plant nutrients and biologicals products and they exported their products to over 34 countries.

The company is led by a set of experienced Promoters. Om Prakash Aggarwal, Chairman, provides strategic direction to the team and has over 30 years of experience and knowledge of the industry. Sanjay Aggarwal, Managing Director, has been associated with the Company since its inception and has an experience of over 30 years in the industry.

The Revenues from operations for the period ended on Dec 31, 2024, Fiscals ended 2024, 2023 and 2022 were ₹  4,663.06 Million, ₹ 5,557.87 Million, ₹  5,521.89 Million and ₹ 4,902.30 Million respectively. The EBITDA for the period ended on Dec 31, 2024, Fiscals ended 2024, 2023 and 2022 were ₹  468.95 Million, ₹ 592.97 Million, ₹  515.73 Million, and ₹ 502.63 Million, respectively. The Profit after Tax for the period ended on Dec 31, 2024, Fiscals ended 2024, 2023 and 2022 were ₹  217.77 Million, ₹ 284.03 Million, ₹  227.35 Million, and ₹ 262.68 Million respectively. This indicates a steady growth in financial performance.
The Company Key Performance Indicates the pre-issue EPS of ₹ 11.94 and post-issue EPS of ₹ 4.49 for FY24. The pre-issue P/E ratio is 9.30x, while the post-issue P/E ratio is 24.70x against the Industrt P/E ratio is 39x. The company's ROCE for FY24 is 18.82%, ROE for FY24 is 12.19% and RoNW is 12.19%. The Annulaised EPS is ₹ 4.59 and annualised P/E Ratio is 24.16x. These metrics suggest that the IPO is fairly priced.

The Grey Market Premium (GMP) of Indogulf Cropsciences showing listing gains of 9.90 %.Given the company's financial performance and the valuation of the IPO, we recommend Risky Investors to Apply to the Indogulf Cropsciences Limited IPO for Listing gain.


Disclaimer: The information provided in this IPO review is for educational and informational purposes only and should not be construed as financial advice or an offer to buy or sell securities. The review must not be used as a singular basis of any investment decision. The views herein are of a general nature and do not consider the risk appetite or the particular circumstances of an individual investor; readers are requested to take professional advice before investing. Nothing in this document should be construed as investment advice. The content is based on publicly available information and market perceptions as of the date of publication and is subject to change. Neither the author nor the website is responsible for any losses or damages arising from the use of this information. 1.“Registration granted by SEBI, membership of a SEBI recognized supervisory body (if any) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.” 2. “Investment in securities market are subject to market risks. Read all the related documents carefully before investing.” 3. To read the Disclaimers, Disclosures, Investor Charter, Investor Complaints please visit our website abhayvarn.com

About the Author
CA Abhay Kumar (Also known as  CA Abhay Varn) is a qualified Chartered Accountant by profession and cleared CA at age 21. He is a SEBI Registered Research Analyst with Registration Number - INH300008465. He Possesses 8+ years of experience in the Stock Market Field and has also worked in Big CA firms.

4,663.06 Million, ₹ 5,557.87 Million, ₹  5,521.89 Million and ₹ 4,902.30 Million respectively. The EBITDA for the period ended on Dec 31, 2024, Fiscals ended 2024, 2023 and 2022 were ₹  468.95 Million, ₹ 592.97 Million, ₹  515.73 Million, and ₹ 502.63 Million, respectively. The Profit after Tax for the period ended on Dec 31, 2024, Fiscals ended 2024, 2023 and 2022 were ₹  217.77 Million, ₹ 284.03 Million, ₹  227.35 Million, and ₹ 262.68 Million respectively. This indicates a steady growth in financial performance.
The Company Key Performance Indicates the pre-issue EPS of ₹ 11.94 and post-issue EPS of ₹ 4.49 for FY24. The pre-issue P/E ratio is 9.30x, while the post-issue P/E ratio is 24.70x against the Industrt P/E ratio is 39x. The company's ROCE for FY24 is 18.82%, ROE for FY24 is 12.19% and RoNW is 12.19%. The Annulaised EPS is ₹ 4.59 and annualised P/E Ratio is 24.16x. These metrics suggest that the IPO is fairly priced.

The Grey Market Premium (GMP) of Indogulf Cropsciences showing listing gains of 9.90 %.Given the company's financial performance and the valuation of the IPO, we recommend Risky Investors to Apply to the Indogulf Cropsciences Limited IPO for Listing gain.


Disclaimer: The information provided in this IPO review is for educational and informational purposes only and should not be construed as financial advice or an offer to buy or sell securities. The review must not be used as a singular basis of any investment decision. The views herein are of a general nature and do not consider the risk appetite or the particular circumstances of an individual investor; readers are requested to take professional advice before investing. Nothing in this document should be construed as investment advice. The content is based on publicly available information and market perceptions as of the date of publication and is subject to change. Neither the author nor the website is responsible for any losses or damages arising from the use of this information. 1.“Registration granted by SEBI, membership of a SEBI recognized supervisory body (if any) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.” 2. “Investment in securities market are subject to market risks. Read all the related documents carefully before investing.” 3. To read the Disclaimers, Disclosures, Investor Charter, Investor Complaints please visit our website abhayvarn.com

About the Author
CA Abhay Kumar (Also known as  CA Abhay Varn) is a qualified Chartered Accountant by profession and cleared CA at age 21. He is a SEBI Registered Research Analyst with Registration Number - INH300008465. He Possesses 8+ years of experience in the Stock Market Field and has also worked in Big CA firms.

-->

Services

FNO Stocks with CA Abhay

Equity Investment with CA Abhay

Option Trading with CA Abhay

Equity Trading with CA Abhay

Stock Market Masterclass

onlyfans leakedonlyfan leaksonlyfans leaked videos